Alaunos Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$1.89(as of Oct 29, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Alaunos Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$1.89
Ticker SymbolTCRT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1
CountyUSA
Market Cap$4.9M
EBIDTA-4.1M
10-Day Moving Average2.53
P/E Ratio0.00
20-Day Moving Average1.92
Forward P/E Ratio18.48
50-Day Moving Average1.63
Earnings per Share-2.12
200-Day Moving Average2.34
Profit Margin0.00%
RSI49.09
Shares Outstanding2.4M
ATR0.48
52-Week High4.59
Volume447,234
52-Week Low1.67
Most Recent Support Level1.88
Book Value0.0M
Most Recent Resistance Level2.19
P/B Ratio0.00
Upper Keltner3.01
P/S Ratio0.00
Lower Keltner0.84
Debt-to-Equity Ratio0.00
Next Earnings Date11/13/2026
Cash Surplus0.0M
Next Ex-Dividend DateUnknown

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.

Alaunos Therapeutics Inc In Our Stock Scanner

As of Oct 29, 2026
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Bull FlagScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.